Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05721859 · ClinicalTrials.gov registry record
M-Vizion™ Macroscopic Radiographic Study
A clinical trial of Revision Hip Arthroplasty, sponsored by Medacta U.
- Recruiting
- Registry status
- 70
- Enrollment target
- 7
- Study locations
NCT05721859 is a study of Revision Hip Arthroplasty that is actively recruiting participants, run by Medacta U. The registered enrollment target is 70 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT05721859, a study of Revision Hip Arthroplasty, is actively recruiting participants, sponsored by Medacta U.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 7
- Study locations
Study Summary
Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
Conditions Studied
Interventions
- DEVICE revision hip arthroplasty
Study Locations (7)
Massachusetts
- New England Baptist Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Illinois
- Northwestern Medicine - Chicago
New Hampshire
- Dartmouth Health - Lebanon
North Carolina
- OrthoCarolina Research Institute, Inc. - Charlotte
Pennsylvania
- Geisinger Medical Center - Danville
Utah
- University of Utah Department of Orthopaedics - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05721859
The ClinicalTrials.gov registry entry for NCT05721859 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medacta U, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Revision Hip Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which revision hip arthroplasty is the first listed.
NCT05721859 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, Illinois, New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05721859 about?
NCT05721859 is a clinical study titled "M-Vizion™ Macroscopic Radiographic Study". Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
What is the current status of trial NCT05721859?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2022-10-12. Estimated completion is 2026-06-01.
What conditions does trial NCT05721859 study?
This clinical trial studies the following conditions: Revision Hip Arthroplasty.
What interventions are being tested in trial NCT05721859?
The interventions under investigation include: revision hip arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT05721859?
This trial is sponsored by Medacta U, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05721859 being conducted?
This trial has 7 study locations across Illinois, Massachusetts, New Hampshire, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.